SKBI [SKYSTAR BIO-PHARMACEUTICAL] EFFECT: (Original Filing)

[.FormData {color: blue; background-color: white; font-size: small; font-family: Times, serif} .SmallFormData {color: blue; background-color: white; font-size: x-small; font-family: Times, serif} .FootnoteData {color: green; background-color: white; font-size: x-small; font-family: Times, serif} .FormText {font-size: x-small; font-family: arial, helvetica,ns-serif} .SmallFormText {font-size: xx-small; font-family: arial, helvetica,ns-serif} .FormTitle {font-size: medium; font-family: arial, helvetica,ns-serif; font-weight: bold} .FormName {font-size: large; font-family: arial,]

By | 2016-02-05T02:36:13+00:00 December 18th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3/A: (Original Filing)

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]

By | 2016-03-01T03:43:27+00:00 December 16th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3/A: ORM Pre-effective Amendment No. 1 to F REGISTRATION

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code,] [Schiff Hardin LLP Letterhead [ December 16, 2013 Board of Directors Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when any applicable] [[Emmel & Klegerman PC Letterhead] December 16, 2013 Skystar Bio-Pharmaceutical Company 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xi’an, Shaanxi Province, P.R. China Ladies and Gentlemen: Skystar Bio-Pharmaceutical Company December 16, 2013 Page 2 In connection with this opinion letter, we have examined and relied upon copies of the following documents, together with such other documents]

By | 2016-03-01T03:47:24+00:00 December 16th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3/A: (Original Filing)

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China] [Schiff Hardin Letterhead [ December 16, 2013 Board of Directorsystar Bio-Pharmaceuticalmpany 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when] [[Emmel & Klegerman PC Letterhead] December 16, 2013ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Ladies and Gentlemen:ystar Bio-Pharmaceuticalmpany December 16, 2013 Page 2 Innnection with this opinion letter, we have examined and relied uponpies of the following documents, together with such other documents we]

By | 2016-02-05T02:37:54+00:00 December 16th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3/A: ORM Pre-effective Amendment No. 1 to F REGISTRATION

[ORM Pre-effective Amendment No. 1 to F REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China] [Schiff Hardin Letterhead [ December 16, 2013 Board of Directorsystar Bio-Pharmaceuticalmpany 4/F Building B, Chuangye Square, No. 48 Keji Road, Gaoxin District, Xian, Shaanxi Province, P.R. China Re Registration Statement on Form S-3 Ladies and Gentlemen: Based on the foregoing and subject to the qualifications set forth below, we are of the opinion that, when] [[Emmel & Klegerman PC Letterhead] December 16, 2013ystar Bio-Pharmaceuticalmpany 4/F, Building B, Chuangye Square, No. 48 Keji Rd Gaoxin District, Xian, Shaanxi Province, P.R. China Ladies and Gentlemen:ystar Bio-Pharmaceuticalmpany December 16, 2013 Page 2 Innnection with this opinion letter, we have examined and relied uponpies of the following documents, together with such other documents we]

By | 2016-02-05T02:38:44+00:00 December 16th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]

By | 2016-03-01T03:51:18+00:00 December 4th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Skystar Bio-Pharmaceutical Company Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer of incorporation or organization) Code Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xi’an, Shaanxi Province, P.R. China (8629) 8819-3188 (Address, including zip code, and telephone number, Bing Mei] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SENIOR DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 8 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8] [SKYSTAR BIO-PHARMACEUTICAL COMPANY TO AS TRUSTEE INDENTURE DATED AS OF , 20 SUBORDINATED DEBT SECURITIES TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 1.1 DEFINITIONS 1 SECTION 1.2 COMPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our report dated April 1, 2013 relating to the consolidated financial statements, which appears in Skystar Bio-Pharmaceutical Company’s Annual Report on Form 10-K for the year ended December 31, 2012. We also consent to] [Consent of Independent Registered Public Accounting Firm We consent to the incorporation by reference in this Registration Statement on Form S-3 and related Prospectus of Skystar Bio-Pharmaceutical Company of our report dated March 30, 2012 relating to the December 31, 2011 consolidated financial statements appearing in the Annual Report on Form 10-K of Skystar Bio-Pharmaceutical Company for the year ended]

By | 2016-03-01T03:52:10+00:00 December 4th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: (Original Filing)

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]

By | 2016-02-05T02:39:43+00:00 December 4th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL] S-3: FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT

[FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933ystar Bio-Pharmaceuticalmpany Nevada 2834 33-0901534 (State or other jurisdiction (Primary Standard Industrial (I.R.S. Employer oforporation or organization)de Number) Identification Number) 4/F Building B Chuangye Square, No. 48 Keji Road, Gaoxin District Xian, Shaanxi Province, P.R. China (8629) 8819-3188] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SENIOR DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 8 SECTION1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 8 SECTION1.4 ACTS OF HOLDERS; RECORDTES] [SKYSTAR BIO-PHARMACEUTICALMPANY TO TRUSTEE INDENTURETED OF , 20 SUBORDINATED DEBT SECURITIES TABLE OFNTENTS Page ARTICLE1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION1.1 DEFINITIONS 1 SECTION1.2MPLIANCE CERTIFICATES AND OPINIONS 9 SECTION 1.3 FORM OF DOCUMENTS DELIVERED TO TRUSTEE 10 SECTION 1.4 ACTS OF HOLDERS; RECORDTES] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We herebynsent to theorporation by reference in the Registration Statement on Form S-3 and related Prospectus of our reportted April 1, 2013 relating to thensolidated financial statements, which appears inystar Bio-Pharmaceuticalmpanys Annual Report on Form 10-K for the year ended December 31, 2012.] [Consent of Independent Registered Public Accounting Firm Wensent to theorporation by reference in this Registration Statement on Form S-3 and related Prospectus ofystar Bio-Pharmaceuticalmpany of our reportted March 30, 2012 relating to the December 31, 2011nsolidated financial statements appearing in the Annual Report on Form 10-K ofystar Bio-Pharmaceuticalmpany for the year ended December 31, 2012,]

By | 2016-02-05T02:40:33+00:00 December 4th, 2013|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. November 14, 2013 Bing Mei Chief Financial Officer]

By | 2016-03-01T03:53:33+00:00 November 14th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More
Skip to toolbar